EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Coumarin derivatives ameliorate the intestinal inflammation and pathogenic gut microbiome changes in the model of infectious colitis through antibacterial activity

Hui-Su Jung, Yei Ju Park, Bon-Hee Gu, Goeun Han, Woonhak Ji, Su Mi Hwang, Myunghoo Kim

Frontiers in Cellular and Infection Microbiology · 2024

DOI: 10.3389/fcimb.2024.1362773 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Hui-Su Jung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Animal Immunology, Department of Animal Science, College of Natural Resource & Life Science, Pusan National University, Miryang, Republ…. Hauptthemen laut MEDLINE: Coumarins, Gastrointestinal Microbiome, Disease Models, Animal, Colitis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coumarin, a phenolic compound, is a secondary metabolite produced by plants such as Tanga and Lime. Coumarin derivatives were prepared via Pechmann condensation. In this study, we performed in vitro and in vivo experiments to determine the antimicrobial and gut immune-regulatory functions of coumarin derivatives. For the in vitro antimicrobial activity assay, coumarin derivatives C1 and C2 were selected based on their pathogen-killing activity against various pathogenic microbes. We further demonstrated that the selected coumarin derivatives disrupted bacterial cell membranes. Next, we examined the regulatory function of the coumarin derivatives in gut inflammation using an infectious colitis model. In an in vivo infectious colitis model, administration of selected C1 coumarin derivatives reduced pathogen loads, the number of inflammatory immune cells (Th1 cells and Th17 cells), and inflammatory cytokine levels (IL-6 and IL-1b) in the intestinal tissue after pathogen infection. In addition, we found that the administration of C1 coumarin derivatives minimized abnormal gut microbiome shift-driven pathogen infection. Potential pathogenic gut microbes, such as Enterobacteriaceae and Staphylococcaceae , were increased by pathogen infection. However, this pathogenic microbial expansion was minimized and beneficial bacteria, such as Ligilactobacillus and Limosilactobacillus , increased with C1 coumarin derivative treatment. Functional gene enrichment assessment revealed that the relative abundance of genes associated with lipid and nucleotide metabolism was reduced by pathogen infection; however, this phenomenon was not observed in C1 coumarin derivative-treated animals. Collectively, our data suggest that C1 coumarin derivative is effective antibacterial agents that minimize pathogen-induced gut inflammation and abnormal gut microbiome modulation through their antibacterial activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoumarinsGastrointestinal MicrobiomeDisease Models, AnimalColitisAnti-Bacterial AgentsAnimalsMiceCytokinesBacteriaMice, Inbred C57BLInflammationTh17 CellsTh1 CellsMale

Stichwörter der Autor:innen

anti-inflammationantibacterial activitycoumarin derivativegut immunitygut microbiome

Substanzen

CoumarinsAnti-Bacterial AgentsCytokinescoumarin

Autor:innen und Institutionen

  • Laboratory of Animal Immunology, Department of Animal Science, College of Natural Resource & Life Science, Pusan National University, Miryang, Republic of Korea.
  • R & D Center, EyeGene, Goyang, Republic of Korea.
  • Life and Industry Convergence Research Institute, Pusan National University, Miryang, Republic of Korea.
  • Future Earth Research Institute, PNU JYS Science Academy, Pusan National University, Busan, Republic of Korea.
  • Department of Biomedical Laboratory Science, College of Health and Medical Science, Sangji University, Wonju, Republic of Korea.

Zitieren

APA

Jung, H. S., Park, Y. J., Gu, B. H., Han, G., Ji, W., Hwang, S. M., & Kim, M. (2024). Coumarin derivatives ameliorate the intestinal inflammation and pathogenic gut microbiome changes in the model of infectious colitis through antibacterial activity. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1362773

Vancouver

Jung HS, Park YJ, Gu BH, Han G, Ji W, Hwang SM, et al. Coumarin derivatives ameliorate the intestinal inflammation and pathogenic gut microbiome changes in the model of infectious colitis through antibacterial activity. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1362773

BibTeX
@article{Jung2024,
  author = {Jung, Hui-Su and Park, Yei Ju and Gu, Bon-Hee and Han, Goeun and Ji, Woonhak and Hwang, Su Mi and Kim, Myunghoo},
  title = {Coumarin derivatives ameliorate the intestinal inflammation and pathogenic gut microbiome changes in the model of infectious colitis through antibacterial activity},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  doi = {10.3389/fcimb.2024.1362773}
}
Kostenlos starten →